1 Min Read
March 19 (Reuters) - Protalix Biotherapeutics Inc:
* PROTALIX BIOTHERAPEUTICS ANNOUNCES ACCEPTANCE OF ABSTRACT ON OPRX-106 AS A LECTURE PRESENTATION AT THE DIGESTIVE DISEASES WEEK® 2018 Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.